In summary, this study has revealed metabolic signatures associated with acquired EGFR TKI resistance that may be linked to the underlying drug resistance mechanisms as well as aggressive growth patterns in HNSCC models. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.